Figure 2
From: Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?
Median percent change from baseline and between-treatment differences (A40+EZ minus A80) in cholesterol content of lipoprotein subclasses (LDL-C 1-4 ) after treatment with ezetimibe added to atorvastatin 40 mg vs doubling to atorvastatin 80 mg for 6 weeks in the overall population and in subgroups with baseline triglyceride <150 or ≥150 mg/dL. Numbers below bars in figures B and C represent the between-treatment difference (95% confidence interval). B. Baseline triglycerides <150 mg/dL. C. Baseline triglycerides ≥150 mg/dL.